Welcome to AlzeCure Pharma’s website. In order to optimize your use of our website we use cookies. If you want more information about our cookie policy, please read more here. By continuing, you agree to our use of cookies.

OK

AlzeCure Pharma logo

Loading..
Svenska
Svenska
  • About the company
    About the company
      • AlzeCure Pharma in brief
      • Vision and strategy
      • Corporate responsibility
      • Organization
        • Management team
        • Board of directors
        • Scientific advisors
        • Partners
      • History
      • Career
  • Research & development
    Research & development
      • Project overview
      • NeuroRestore
      • Alzstatin
      • Alzheimer’s disease
      • Publications
  • Governance
    Governance
      • Corporate Governance Reports
      • General meeting
        • General meetings
      • Board of directors
      • Management team
      • Remuneration
      • Auditors
      • Articles of association
  • Investors
    Investors
      • AlzeCure Pharma on First North
        • First North Certified Adviser
      • The share
        • Trading information
        • Sharecapital development
        • Dividend policy
        • Ownership structure
      • Financial reports
      • Financial calendar
      • Subscribe
      • Contact
  • Media
    Media
      • Press releases
      • Image bank
      • Subscribe
      • Contact
  • Contact
    Contact
      • Office
      • Investors
      • Media
  • Listing First North Premier
    Listing First North Premier
      • Press releases
      • Prospectus
      • Key dates
      • Contact

Media

Mikael Widell
Mikael Widell
Head of Communications and IR
mikael.widell@alzecurepharma.com
+46 703 11 99 60
Share
  • Contact
    • Office
    • Investors
    • Media
About the company
  • AlzeCure Pharma in brief
  • Vision and strategy
  • Corporate responsibility
  • Organization
  • Career
  • History
Research & development
  • Project overview
  • NeuroRestore
  • Alzstatin
  • Alzheimer’s disease
  • Publications
Governance
  • Corporate Governance Reports
  • General meeting
  • Board of directors
  • Management team
  • Remuneration
  • Auditors
  • Articles of association
Investors
  • AlzeCure Pharma on First North
  • The share
  • Financial reports
  • Financial calendar
  • Subscribe
  • Contact
Media
  • Press releases
  • Image bank
  • Subscribe
  • Contact
Contact
  • Office
  • Investors
  • Media

AlzeCure Pharma AB, Hälsovägen 7,  SE-141 57 Huddinge, Sweden. Phone: +46 703 73 88 24. Registration number: 559094-8302.

  • About cookies
  • Privacy policy